Skip to main content
. 2022 Jan 24;48(1):e20210366. doi: 10.36416/1806-3756/e20210366

Figure 3. Positive predictive value in the non-fibrotic pulmonary sarcoidosis group (n = 158) for persistent course according to stages A (0-1 point), B (2-3 points) and C (≥ 4 points). p < 0.01.

Figure 3